相似文献
1
Fecal microbiota transplantation for the management of Clostridium difficile infection.粪菌移植用于艰难梭菌感染的治疗
Infect Dis Clin North Am. 2015 Mar;29(1):109-22. doi: 10.1016/j.idc.2014.11.009.
2
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
3
Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.粪便微生物群移植成功治疗艰难梭菌感染
J Physiol Pharmacol. 2016 Dec;67(6):859-866.
4
Faecal microbiota transplantation for Clostridium difficile infection.粪便微生物群移植治疗艰难梭菌感染
Int J Clin Pract. 2014 Mar;68(3):363-8. doi: 10.1111/ijcp.12320. Epub 2013 Dec 22.
5
Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome.粪便微生物群移植对2例复发性艰难梭菌感染患儿的疗效及其对生长和肠道微生物组的影响
J Pediatr Gastroenterol Nutr. 2014 Nov;59(5):565-70. doi: 10.1097/MPG.0000000000000495.
6
Fecal microbiota transplantation for the treatment of Clostridium difficile infection.粪便微生物群移植治疗艰难梭菌感染
J Hosp Med. 2016 Jan;11(1):56-61. doi: 10.1002/jhm.2449. Epub 2015 Sep 7.
7
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.粪便微生物移植治疗艰难梭菌感染：系统评价。
Ann Intern Med. 2015 May 5;162(9):630-8. doi: 10.7326/M14-2693.
8
Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.粪便微生物群移植——复发性艰难梭菌感染及其他疾病的治疗方法。
Postepy Hig Med Dosw (Online). 2017 Mar 27;71(0):220-226. doi: 10.5604/01.3001.0010.3807.
9
Recovery of the gut microbiome following fecal microbiota transplantation.粪便微生物群移植后肠道微生物群的恢复
mBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.
10
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.造血干细胞移植受者复发性艰难梭菌感染的粪便微生物群移植
Transpl Infect Dis. 2016 Aug;18(4):628-33. doi: 10.1111/tid.12550. Epub 2016 Jul 5.
引用本文的文献
1
Lactiplantibacillus plantarum GMNL-661 Ameliorates Clostridioides difficile Infection and Reconfigures Intestinal Microbiota in a Murine Model.植物乳杆菌GMNL-661改善艰难梭菌感染并重塑小鼠模型中的肠道微生物群。
Probiotics Antimicrob Proteins. 2025 May 6. doi: 10.1007/s12602-025-10556-9.
2
Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview.人工关节感染中的抑制性抗生素治疗：当代概述
Antibiotics (Basel). 2025 Mar 7;14(3):277. doi: 10.3390/antibiotics14030277.
3
Reevaluating Biota Alteration: Reframing Environmental Influences on Chronic Immune Disorders and Exploring Novel Therapeutic Opportunities.重新评估生物群改变：重新构建环境对慢性免疫性疾病的影响，并探索新的治疗机会。
Yale J Biol Med. 2024 Jun 28;97(2):253-263. doi: 10.59249/VUNF1315. eCollection 2024 Jun.
4
A Colonic Organoid Model Challenged with the Large Toxins of TcdA and TcdB Exhibit Deregulated Tight Junction Proteins.一种结肠类器官模型受到 TcdA 和 TcdB 的大毒素的挑战，表现出紧密连接蛋白失调。
Toxins (Basel). 2023 Nov 4;15(11):643. doi: 10.3390/toxins15110643.
5
Tobramycin Nanoantibiotics and Their Advantages: A Minireview.妥布霉素纳米抗生素及其优势：简述。
Int J Mol Sci. 2022 Nov 15;23(22):14080. doi: 10.3390/ijms232214080.
6
In Vitro and In Vivo Anti- Effect of a Probiotic Strain.体外和体内抗益生菌菌株的作用。
J Microbiol Biotechnol. 2022 Jan 28;32(1):46-55. doi: 10.4014/jmb.2107.07057.
7
Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective.人工关节感染中的抑制性抗生素治疗：一种观点
Antibiotics (Basel). 2021 Jun 19;10(6):743. doi: 10.3390/antibiotics10060743.
8
Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.早期、重复粪菌移植成功治疗严重、难治性艰难梭菌结肠炎。
Am J Health Syst Pharm. 2021 Jul 22;78(15):1374-1381. doi: 10.1093/ajhp/zxab161.
9
Primary Human Dendritic Cells and Whole-Blood Based Assays to Evaluate Immuno-Modulatory Properties of Heat-Killed Commensal Bacteria.用于评估热灭活共生细菌免疫调节特性的原代人树突状细胞和全血检测方法
Vaccines (Basel). 2021 Mar 5;9(3):225. doi: 10.3390/vaccines9030225.
10
Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review.比较粪便微生物群移植与抗生素治疗复发性艰难梭菌感染的卫生经济评估：一项系统评价
Health Econ Rev. 2021 Jan 13;11(1):3. doi: 10.1186/s13561-021-00301-7.
本文引用的文献
1
Treatment of Recurrent Diarrhea.复发性腹泻的治疗
Gastroenterol Hepatol (N Y). 2006 Mar;2(3):203-208.
2
Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.口服、胶囊化、冷冻粪菌移植治疗复发性艰难梭菌感染。
JAMA. 2014 Nov 5;312(17):1772-8. doi: 10.1001/jama.2014.13875.
3
Recovery of the gut microbiome following fecal microbiota transplantation.粪便微生物群移植后肠道微生物群的恢复
mBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.
4
Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.艰难梭菌感染复发、并发症及死亡率的危险因素：一项系统评价
PLoS One. 2014 Jun 4;9(6):e98400. doi: 10.1371/journal.pone.0098400. eCollection 2014.
5
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.粪便微生物移植治疗免疫功能低下患者的艰难梭菌感染。
Am J Gastroenterol. 2014 Jul;109(7):1065-71. doi: 10.1038/ajg.2014.133. Epub 2014 Jun 3.
6
Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.使用来自非亲属供体的冷冻接种物进行粪便微生物群移植治疗复发性艰难梭菌感染：一项随机、开放标签、对照的试点研究。
Clin Infect Dis. 2014 Jun;58(11):1515-22. doi: 10.1093/cid/ciu135. Epub 2014 Apr 23.
7
Tempered enthusiasm for fecal transplant.对粪便移植的审慎热情。
Clin Infect Dis. 2014 Jul 15;59(2):319. doi: 10.1093/cid/ciu278. Epub 2014 Apr 23.
8
Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children.系统评价：粪便微生物群移植治疗成人和儿童的消化系统和非消化系统疾病。
Aliment Pharmacol Ther. 2014 May;39(10):1003-32. doi: 10.1111/apt.12699. Epub 2014 Mar 18.
9
Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.肠道微生物群在抵抗艰难梭菌定植中的作用。
Gastroenterology. 2014 May;146(6):1547-53. doi: 10.1053/j.gastro.2014.01.059. Epub 2014 Feb 4.
10
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.抗生素引起的小鼠肠道微生物群和代谢组变化会增加其对艰难梭菌感染的易感性。
Nat Commun. 2014;5:3114. doi: 10.1038/ncomms4114.
Zotero 插件